{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:39:51Z","timestamp":1789072791148,"version":"build-2803163510"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT23510"],"award-info":[{"award-number":["IT23510"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT23510"],"award-info":[{"award-number":["IT23510"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","award":["RES0052505"],"award-info":[{"award-number":["RES0052505"]}],"id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03383-z","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:27:03Z","timestamp":1748269623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psilocybin mitigates behavioral despair and cognitive impairment in treatment-resistant depression model using wistar kyoto rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Zitong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"van Bruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaisa","family":"Sandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"3383_CR1","unstructured":"Bains, N. & Abdijadid, S. In StatPearls (StatPearls Publishing Copyright \u00a9 2024 (StatPearls Publishing LLC., 2024)."},{"key":"3383_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12888-023-04581-7","volume":"23","author":"P Chodavadia","year":"2023","unstructured":"Chodavadia, P., Teo, I., Poremski, D., Fung, D. S. S. & Finkelstein, E. A. Prevalence and economic burden of depression and anxiety symptoms among Singaporean adults: results from a 2022 web panel. BMC Psychiatry. 23, 104. https:\/\/doi.org\/10.1186\/s12888-023-04581-7 (2023).","journal-title":"BMC Psychiatry"},{"key":"3383_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jad.2011.12.036","volume":"140","author":"BH Hidaka","year":"2012","unstructured":"Hidaka, B. H. Depression as a disease of modernity: explanations for increasing prevalence. J. Affect. Disord. 140, 205\u2013214. https:\/\/doi.org\/10.1016\/j.jad.2011.12.036 (2012).","journal-title":"J. Affect. Disord"},{"key":"3383_CR4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/s2045796021000779","volume":"31","author":"YY Su","year":"2022","unstructured":"Su, Y. Y. et al. Specific and cumulative lifetime stressors in the aetiology of major depression: A longitudinal community-based population study. Epidemiol. Psychiatr Sci. 31, e3. https:\/\/doi.org\/10.1017\/s2045796021000779 (2022).","journal-title":"Epidemiol. Psychiatr Sci."},{"key":"3383_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0706743716659418","volume":"61","author":"SV Parikh","year":"2016","unstructured":"Parikh, S. V. et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: sect.\u00a02. Psychological treatments. Can. J. Psychiatry. 61, 524\u2013539. https:\/\/doi.org\/10.1177\/0706743716659418 (2016).","journal-title":"Can. J. Psychiatry"},{"key":"3383_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jad.2021.03.029","volume":"287","author":"FH Gronemann","year":"2021","unstructured":"Gronemann, F. H. et al. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder. J. Affect. Disord. 287, 204\u2013213. https:\/\/doi.org\/10.1016\/j.jad.2021.03.029 (2021).","journal-title":"J. Affect. Disord"},{"key":"3383_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/2045125312445469","volume":"2","author":"E Penn","year":"2012","unstructured":"Penn, E. & Tracy, D. K. The drugs don\u2019t work? Antidepressants and the current and future Pharmacological management of depression. Ther. Adv. Psychopharmacol. 2, 179\u2013188. https:\/\/doi.org\/10.1177\/2045125312445469 (2012).","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"3383_CR8","doi-asserted-by":"publisher","unstructured":"Andrade, C. Psychotropic drugs with long Half-Lives: implications for drug discontinuation, occasional missed doses, dosing interval, and pregnancy planning. J. Clin. Psychiatry. 83 https:\/\/doi.org\/10.4088\/JCP.22f14593 (2022).","DOI":"10.4088\/JCP.22f14593"},{"key":"3383_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/02698811211073759","volume":"36","author":"N Gukasyan","year":"2022","unstructured":"Gukasyan, N. et al. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up. J. Psychopharmacol. 36, 151\u2013158. https:\/\/doi.org\/10.1177\/02698811211073759 (2022).","journal-title":"J. Psychopharmacol."},{"key":"3383_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tips.2023.12.007","volume":"45","author":"F Reed","year":"2024","unstructured":"Reed, F. & Foldi, C. J. Do the therapeutic effects of psilocybin involve actions in the gut? Trends Pharmacol. Sci. 45, 107\u2013117. https:\/\/doi.org\/10.1016\/j.tips.2023.12.007 (2024).","journal-title":"Trends Pharmacol. Sci."},{"key":"3383_CR11","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin, G. M. et al. Single-Dose psilocybin for a Treatment-Resistant episode of major depression. N Engl. J. Med. 387, 1637\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa2206443 (2022).","journal-title":"N Engl. J. Med."},{"key":"3383_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","volume":"5","author":"JD Rosenblat","year":"2024","unstructured":"Rosenblat, J. D. et al. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. Med 5, 190\u2013200e195. https:\/\/doi.org\/10.1016\/j.medj.2024.01.005 (2024).","journal-title":"Med"},{"key":"3383_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/s0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357\u20131366. https:\/\/doi.org\/10.1016\/s0140-6736(17)32802-7 (2018).","journal-title":"Lancet"},{"key":"3383_CR14","doi-asserted-by":"publisher","first-page":"647909","DOI":"10.3389\/fpsyt.2021.647909","volume":"12","author":"K Mans","year":"2021","unstructured":"Mans, K. et al. Multifaceted improvements in mental Well-Being following psychedelic experiences in a prospective opportunity sample. Front. Psychiatry. 12, 647909. https:\/\/doi.org\/10.3389\/fpsyt.2021.647909 (2021). Sustained.","journal-title":"Front. Psychiatry"},{"key":"3383_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","volume":"48","author":"AE Calder","year":"2023","unstructured":"Calder, A. E. & Hasler, G. Towards an Understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology 48, 104\u2013112. https:\/\/doi.org\/10.1038\/s41386-022-01389-z (2023).","journal-title":"Neuropsychopharmacology"},{"key":"3383_CR16","doi-asserted-by":"publisher","first-page":"111243","DOI":"10.1016\/j.pnpbp.2024.111243","volume":"136","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats. Prog Neuropsychopharmacol. Biol. Psychiatry. 136, 111243. https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111243 (2025).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3383_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","volume":"79","author":"HC Lu","year":"2016","unstructured":"Lu, H. C. & Mackie, K. An introduction to the endogenous cannabinoid system. Biol. Psychiatry. 79, 516\u2013525. https:\/\/doi.org\/10.1016\/j.biopsych.2015.07.028 (2016).","journal-title":"Biol. Psychiatry"},{"key":"3383_CR18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2174\/092986710790980005","volume":"17","author":"PH Reggio","year":"2010","unstructured":"Reggio, P. H. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. Curr. Med. Chem. 17, 1468\u20131486. https:\/\/doi.org\/10.2174\/092986710790980005 (2010).","journal-title":"Curr. Med. Chem."},{"key":"3383_CR19","doi-asserted-by":"publisher","first-page":"110825","DOI":"10.1016\/j.pnpbp.2023.110825","volume":"127","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Wistar-Kyoto rats and chronically stressed Wistar rats present similar depression- and anxiety-like behaviors but different corticosterone and endocannabinoid system modulation. Prog Neuropsychopharmacol. Biol. Psychiatry. 127, 110825. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110825 (2023).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3383_CR20","doi-asserted-by":"publisher","unstructured":"Danan, D., Todder, D., Zohar, J., Cohen, H. & Is PTSD-Phenotype associated with HPA-Axis sensitivity?? The endocannabinoid system in modulating stress response in rats. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22126416 (2021).","DOI":"10.3390\/ijms22126416"},{"key":"3383_CR21","doi-asserted-by":"publisher","first-page":"113007","DOI":"10.1016\/j.bbr.2020.113007","volume":"400","author":"D Soriano","year":"2021","unstructured":"Soriano, D., Brusco, A. & Caltana, L. Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1. Behav. Brain Res. 400, 113007. https:\/\/doi.org\/10.1016\/j.bbr.2020.113007 (2021).","journal-title":"Behav. Brain Res."},{"key":"3383_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jnc.13267","volume":"135","author":"R Imperatore","year":"2015","unstructured":"Imperatore, R. et al. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB\u2081R signaling and anxiety-like behavior. J. Neurochem. 135, 799\u2013813. https:\/\/doi.org\/10.1111\/jnc.13267 (2015).","journal-title":"J. Neurochem"},{"key":"3383_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","volume":"41","author":"M Morena","year":"2016","unstructured":"Morena, M., Patel, S., Bains, J. S. & Hill, M. N. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology 41, 80\u2013102. https:\/\/doi.org\/10.1038\/npp.2015.166 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"3383_CR24","doi-asserted-by":"publisher","unstructured":"Zou, S. & Kumar, U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int. J. Mol. Sci. 19 https:\/\/doi.org\/10.3390\/ijms19030833 (2018).","DOI":"10.3390\/ijms19030833"},{"key":"3383_CR25","doi-asserted-by":"publisher","first-page":"1209419","DOI":"10.3389\/fpsyt.2024.1209419","volume":"15","author":"P Wolfson","year":"2024","unstructured":"Wolfson, P. & Vaid, G. Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective-a new and evolving approach. Front. Psychiatry. 15, 1209419. https:\/\/doi.org\/10.3389\/fpsyt.2024.1209419 (2024).","journal-title":"Front. Psychiatry"},{"key":"3383_CR26","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1038\/s41467-020-19780-z","volume":"11","author":"W Xu","year":"2020","unstructured":"Xu, W. et al. Endocannabinoid signaling regulates the reinforcing and psychostimulant effects of ketamine in mice. Nat. Commun. 11, 5962. https:\/\/doi.org\/10.1038\/s41467-020-19780-z (2020).","journal-title":"Nat. Commun."},{"key":"3383_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2019.01.059","volume":"699","author":"DDF Pacheco","year":"2019","unstructured":"Pacheco, D. D. F., Romero, T. R. L. & Duarte, I. D. G. Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB(1) receptors. Neurosci. Lett. 699, 140\u2013144. https:\/\/doi.org\/10.1016\/j.neulet.2019.01.059 (2019).","journal-title":"Neurosci. Lett."},{"key":"3383_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/fbp.0000000000000431","volume":"30","author":"P Willner","year":"2019","unstructured":"Willner, P. et al. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression. Behav. Pharmacol. 30, 239\u2013250. https:\/\/doi.org\/10.1097\/fbp.0000000000000431 (2019).","journal-title":"Behav. Pharmacol."},{"key":"3383_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2019.07.007","volume":"105","author":"LR Aleksandrova","year":"2019","unstructured":"Aleksandrova, L. R., Wang, Y. T. & Phillips, A. G. Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response. Neurosci. Biobehav Rev. 105, 1\u201323. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.07.007 (2019).","journal-title":"Neurosci. Biobehav Rev."},{"key":"3383_CR30","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1038\/tp.2016.277","volume":"7","author":"G Ritov","year":"2017","unstructured":"Ritov, G. & Richter-Levin, G. Pre-trauma methylphenidate in rats reduces PTSD-like reactions one month later. Transl Psychiatry. 7, e1000. https:\/\/doi.org\/10.1038\/tp.2016.277 (2017).","journal-title":"Transl Psychiatry"},{"key":"3383_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pnpbp.2019.03.018","volume":"93","author":"F Xue","year":"2019","unstructured":"Xue, F. et al. Early intervention with electroacupuncture prevents PTSD-like behaviors in rats through enhancing hippocampal endocannabinoid signaling. Prog Neuropsychopharmacol. Biol. Psychiatry. 93, 171\u2013181. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.03.018 (2019).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3383_CR32","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1016\/j.jtherbio.2020.102819","volume":"95","author":"CE Chan","year":"2021","unstructured":"Chan, C. E., Lee, Y. U. & Swoap, S. J. Physiological response to the odorant TMT in fully fed and calorically restricted laboratory mice. J. Therm. Biol. 95, 102819. https:\/\/doi.org\/10.1016\/j.jtherbio.2020.102819 (2021).","journal-title":"J. Therm. Biol."},{"key":"3383_CR33","doi-asserted-by":"publisher","first-page":"e12684","DOI":"10.1111\/gbb.12684","volume":"19","author":"RE Tyler","year":"2020","unstructured":"Tyler, R. E., Weinberg, B. Z. S., Lovelock, D. F., Ornelas, L. C. & Besheer, J. Exposure to the predator odor TMT induces early and late differential gene expression related to stress and excitatory synaptic function throughout the brain in male rats. Genes Brain Behav. 19, e12684. https:\/\/doi.org\/10.1111\/gbb.12684 (2020).","journal-title":"Genes Brain Behav."},{"key":"3383_CR34","doi-asserted-by":"publisher","first-page":"891512","DOI":"10.3389\/fpsyt.2022.891512","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang, J., Pham, M., Panenka, W. J., Honer, W. G. & Barr, A. M. Chronic treatment with psilocybin decreases changes in body weight in a rodent model of obesity. Front. Psychiatry. 13, 891512. https:\/\/doi.org\/10.3389\/fpsyt.2022.891512 (2022).","journal-title":"Front. Psychiatry"},{"key":"3383_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/02698811231205692","volume":"37","author":"N Malikowska-Racia","year":"2023","unstructured":"Malikowska-Racia, N., Koniewski, M., Golebiowska, J. & Popik, P. Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats. J. Psychopharmacol. 37, 1149\u20131156. https:\/\/doi.org\/10.1177\/02698811231205692 (2023).","journal-title":"J. Psychopharmacol."},{"key":"3383_CR36","doi-asserted-by":"publisher","first-page":"100410","DOI":"10.1016\/j.ynstr.2021.100410","volume":"15","author":"A Koert","year":"2021","unstructured":"Koert, A. et al. The social instability stress paradigm in rat and mouse: A systematic review of protocols, limitations, and recommendations. Neurobiol. Stress. 15, 100410. https:\/\/doi.org\/10.1016\/j.ynstr.2021.100410 (2021).","journal-title":"Neurobiol. Stress"},{"key":"3383_CR37","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","volume":"126","author":"B Planchez","year":"2019","unstructured":"Planchez, B., Surget, A. & Belzung, C. Animal models of major depression: drawbacks and challenges. J. Neural Transm (Vienna). 126, 1383\u20131408. https:\/\/doi.org\/10.1007\/s00702-019-02084-y (2019).","journal-title":"J. Neural Transm (Vienna)"},{"key":"3383_CR38","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41386-022-01301-9","volume":"47","author":"D De Gregorio","year":"2022","unstructured":"De Gregorio, D. et al. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. Neuropsychopharmacology 47, 1188\u20131198. https:\/\/doi.org\/10.1038\/s41386-022-01301-9 (2022).","journal-title":"Neuropsychopharmacology"},{"key":"3383_CR39","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"MY Liu","year":"2018","unstructured":"Liu, M. Y. et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat. Protoc. 13, 1686\u20131698. https:\/\/doi.org\/10.1038\/s41596-018-0011-z (2018).","journal-title":"Nat. Protoc."},{"key":"3383_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ame2.12107","volume":"3","author":"LW He","year":"2020","unstructured":"He, L. W. et al. Optimization of food deprivation and sucrose preference test in SD rat model undergoing chronic unpredictable mild stress. Anim. Model. Exp. Med. 3, 69\u201378. https:\/\/doi.org\/10.1002\/ame2.12107 (2020).","journal-title":"Anim. Model. Exp. Med."},{"key":"3383_CR41","doi-asserted-by":"crossref","unstructured":"Chesworth, R., Watt, G. & Karl, T. in Handbook of Behavioral Neuroscience Vol. 27 (eds Abdel Ennaceur & Maria Angelica de Souza Silva) 461\u2013488 (Elsevier, 2018).","DOI":"10.1016\/B978-0-12-812012-5.00031-8"},{"key":"3383_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbr.2012.03.022","volume":"232","author":"S Akkerman","year":"2012","unstructured":"Akkerman, S. et al. Object recognition testing: methodological considerations on exploration and discrimination measures. Behav. Brain Res. 232, 335\u2013347. https:\/\/doi.org\/10.1016\/j.bbr.2012.03.022 (2012).","journal-title":"Behav. Brain Res."},{"key":"3383_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes, M. & Biala, G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn. Process. 13, 93\u2013110. https:\/\/doi.org\/10.1007\/s10339-011-0430-z (2012).","journal-title":"Cogn. Process."},{"key":"3383_CR44","doi-asserted-by":"publisher","first-page":"e6036","DOI":"10.1590\/1414-431x20176036","volume":"50","author":"NF Correa-Netto","year":"2017","unstructured":"Correa-Netto, N. F. et al. An ontogenic study of the behavioral effects of chronic intermittent exposure to Ayahuasca in mice. Braz J. Med. Biol. Res. 50, e6036. https:\/\/doi.org\/10.1590\/1414-431x20176036 (2017).","journal-title":"Braz J. Med. Biol. Res."},{"key":"3383_CR45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322\u2013328. https:\/\/doi.org\/10.1038\/nprot.2007.44 (2007).","journal-title":"Nat. Protoc."},{"key":"3383_CR46","doi-asserted-by":"publisher","DOI":"10.3791\/52587","author":"R Yankelevitch-Yahav","year":"2015","unstructured":"Yankelevitch-Yahav, R., Franko, M., Huly, A. & Doron, R. The forced swim test as a model of depressive-like behavior. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52587 (2015).","journal-title":"J. Vis. Exp."},{"key":"3383_CR47","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery, D. A. & Cryan, J. F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 7, 1009\u20131014. https:\/\/doi.org\/10.1038\/nprot.2012.044 (2012).","journal-title":"Nat. Protoc."},{"key":"3383_CR48","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.physbeh.2013.05.012","volume":"118","author":"OV Bogdanova","year":"2013","unstructured":"Bogdanova, O. V., Kanekar, S., D\u2019Anci, K. E. & Renshaw, P. F. Factors influencing behavior in the forced swim test. Physiol. Behav. 118, 227\u2013239. https:\/\/doi.org\/10.1016\/j.physbeh.2013.05.012 (2013).","journal-title":"Physiol. Behav."},{"key":"3383_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pnpbp.2015.02.001","volume":"60","author":"EY Fenton","year":"2015","unstructured":"Fenton, E. Y. et al. Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation. Prog Neuropsychopharmacol. Biol. Psychiatry. 60, 52\u201359. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.02.001 (2015).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3383_CR50","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","volume":"8","author":"KG Commons","year":"2017","unstructured":"Commons, K. G., Cholanians, A. B., Babb, J. A. & Ehlinger, D. G. The rodent forced swim test measures Stress-Coping strategy, not Depression-like behavior. ACS Chem. Neurosci. 8, 955\u2013960. https:\/\/doi.org\/10.1021\/acschemneuro.7b00042 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"3383_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/s0091-3057(96)00402-9","volume":"57","author":"G Griebel","year":"1997","unstructured":"Griebel, G., Rodgers, R. J., Perrault, G. & Sanger, D. J. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol. Biochem. Behav. 57, 817\u2013827. https:\/\/doi.org\/10.1016\/s0091-3057(96)00402-9 (1997).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"3383_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","volume":"49","author":"AP Cruz","year":"1994","unstructured":"Cruz, A. P., Frei, F. & Graeff, F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49, 171\u2013176. https:\/\/doi.org\/10.1016\/0091-3057(94)90472-3 (1994).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"3383_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","volume":"73","author":"A Inserra","year":"2021","unstructured":"Inserra, A., De Gregorio, D. & Gobbi, G. Psychedelics in psychiatry: neuroplastic, Immunomodulatory, and neurotransmitter mechanisms. Pharmacol. Rev. 73, 202\u2013277. https:\/\/doi.org\/10.1124\/pharmrev.120.000056 (2021).","journal-title":"Pharmacol. Rev."},{"key":"3383_CR54","doi-asserted-by":"publisher","unstructured":"Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B. & Thompson, S. M. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. Proc. Natl. Acad. Sci. U S A. 118 https:\/\/doi.org\/10.1073\/pnas.2022489118 (2021).","DOI":"10.1073\/pnas.2022489118"},{"key":"3383_CR55","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1192\/bjo.2023.535","volume":"9","author":"MI Husain","year":"2023","unstructured":"Husain, M. I. et al. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. BJPsych Open. 9, e134. https:\/\/doi.org\/10.1192\/bjo.2023.535 (2023).","journal-title":"BJPsych Open."},{"key":"3383_CR56","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen, M. K. et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma Psilocin levels. Neuropsychopharmacology 44, 1328\u20131334. https:\/\/doi.org\/10.1038\/s41386-019-0324-9 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"3383_CR57","doi-asserted-by":"publisher","first-page":"117456","DOI":"10.1016\/j.neuroimage.2020.117456","volume":"225","author":"J Grandjean","year":"2021","unstructured":"Grandjean, J. et al. Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice. Neuroimage 225, 117456. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117456 (2021).","journal-title":"Neuroimage"},{"key":"3383_CR58","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.biopsych.2007.10.018","volume":"63","author":"JR Schank","year":"2008","unstructured":"Schank, J. R., Liles, L. C. & Weinshenker, D. Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol. Psychiatry. 63, 1007\u20131012. https:\/\/doi.org\/10.1016\/j.biopsych.2007.10.018 (2008).","journal-title":"Biol. Psychiatry"},{"key":"3383_CR59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0091-3057(94)90253-4","volume":"49","author":"RJ Rodgers","year":"1994","unstructured":"Rodgers, R. J., Nikulina, E. M. & Cole, J. C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49, 985\u2013995. https:\/\/doi.org\/10.1016\/0091-3057(94)90253-4 (1994).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"3383_CR60","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon, P. & Grace, A. A. Dopamine system dysregulation in major depressive disorders. Int. J. Neuropsychopharmacol. 20, 1036\u20131046. https:\/\/doi.org\/10.1093\/ijnp\/pyx056 (2017).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"3383_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","volume":"35","author":"A Der-Avakian","year":"2012","unstructured":"Der-Avakian, A. & Markou, A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 35, 68\u201377. https:\/\/doi.org\/10.1016\/j.tins.2011.11.005 (2012).","journal-title":"Trends Neurosci."},{"key":"3383_CR62","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman, J. P. et al. Regulation of the Hypothalamic-Pituitary-Adrenocortical stress response. Compr. Physiol. 6, 603\u2013621. https:\/\/doi.org\/10.1002\/cphy.c150015 (2016).","journal-title":"Compr. Physiol."},{"key":"3383_CR63","doi-asserted-by":"publisher","first-page":"14980","DOI":"10.1523\/jneurosci.4283-10.2010","volume":"30","author":"MN Hill","year":"2010","unstructured":"Hill, M. N. et al. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 30, 14980\u201314986. https:\/\/doi.org\/10.1523\/jneurosci.4283-10.2010 (2010).","journal-title":"J. Neurosci."},{"key":"3383_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/er.2015-1080","volume":"38","author":"H Oster","year":"2017","unstructured":"Oster, H. et al. The functional and clinical significance of the 24-Hour rhythm of Circulating glucocorticoids. Endocr. Rev. 38, 3\u201345. https:\/\/doi.org\/10.1210\/er.2015-1080 (2017).","journal-title":"Endocr. Rev."},{"key":"3383_CR65","first-page":"468","volume":"34","author":"MA Stephens","year":"2012","unstructured":"Stephens, M. A. & Wand, G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res. 34, 468\u2013483 (2012).","journal-title":"Alcohol Res."},{"key":"3383_CR66","doi-asserted-by":"publisher","unstructured":"Mikulska, J., Juszczyk, G., Gawro\u0144ska-Grzywacz, M. & Herbet, M. HPA Axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation. Brain Sci. 11 https:\/\/doi.org\/10.3390\/brainsci11101298 (2021).","DOI":"10.3390\/brainsci11101298"},{"key":"3383_CR67","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.2522\/ptj.20130597","volume":"94","author":"KE Hannibal","year":"2014","unstructured":"Hannibal, K. E. & Bishop, M. D. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys. Ther. 94, 1816\u20131825. https:\/\/doi.org\/10.2522\/ptj.20130597 (2014).","journal-title":"Phys. Ther."},{"key":"3383_CR68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.6000\/1927-5129.2014.10.25","volume":"10","author":"SK Vashist","year":"2014","unstructured":"Vashist, S. K., Schneider, E. M. & Depression An insight and need for personalized psychological stress monitoring and management. J. Basic. Appl. Sci. 10, 177\u2013182 (2014).","journal-title":"J. Basic. Appl. Sci."},{"key":"3383_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1210\/er.2013-1087","volume":"35","author":"C Fekete","year":"2014","unstructured":"Fekete, C. & Lechan, R. M. Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr. Rev. 35, 159\u2013194. https:\/\/doi.org\/10.1210\/er.2013-1087 (2014).","journal-title":"Endocr. Rev."},{"key":"3383_CR70","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1210\/jc.2013-3589","volume":"99","author":"M Medici","year":"2014","unstructured":"Medici, M. et al. Thyroid function within the normal range and the risk of depression: a population-based cohort study. J. Clin. Endocrinol. Metab. 99, 1213\u20131219. https:\/\/doi.org\/10.1210\/jc.2013-3589 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3383_CR71","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1159\/000521650","volume":"112","author":"H Khaleghzadeh-Ahangar","year":"2022","unstructured":"Khaleghzadeh-Ahangar, H., Talebi, A. & Mohseni-Moghaddam, P. Thyroid disorders and development of cognitive impairment: A review study. Neuroendocrinology 112, 835\u2013844. https:\/\/doi.org\/10.1159\/000521650 (2022).","journal-title":"Neuroendocrinology"},{"key":"3383_CR72","doi-asserted-by":"publisher","first-page":"e28201","DOI":"10.7759\/cureus.28201","volume":"14","author":"SP Nuguru","year":"2022","unstructured":"Nuguru, S. P. et al. Hypothyroidism and depression: A narrative review. Cureus 14, e28201. https:\/\/doi.org\/10.7759\/cureus.28201 (2022).","journal-title":"Cureus"},{"key":"3383_CR73","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yhbeh.2011.06.003","volume":"60","author":"DL Helmreich","year":"2011","unstructured":"Helmreich, D. L. & Tylee, D. Thyroid hormone regulation by stress and behavioral differences in adult male rats. Horm. Behav. 60, 284\u2013291. https:\/\/doi.org\/10.1016\/j.yhbeh.2011.06.003 (2011).","journal-title":"Horm. Behav."},{"key":"3383_CR74","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/eje-18-0741","volume":"180","author":"IH Jonsdottir","year":"2019","unstructured":"Jonsdottir, I. H., Sj\u00f6rs & Dahlman A. MECHANISMS IN ENDOCRINOLOGY: endocrine and immunological aspects of burnout: a narrative review. Eur. J. Endocrinol. 180, R147\u2013r158. https:\/\/doi.org\/10.1530\/eje-18-0741 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"3383_CR75","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12020-020-02278-5","volume":"69","author":"R Cai","year":"2020","unstructured":"Cai, R. et al. Association between thyroid function and serum cortisol in cortisol-producing adenoma patients. Endocrine 69, 196\u2013203. https:\/\/doi.org\/10.1007\/s12020-020-02278-5 (2020).","journal-title":"Endocrine"},{"key":"3383_CR76","doi-asserted-by":"publisher","first-page":"1301714","DOI":"10.3389\/fpsyt.2023.1301714","volume":"14","author":"A Toll","year":"2023","unstructured":"Toll, A. et al. Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-na\u00efve first-episode psychosis patients. Front. Psychiatry. 14, 1301714. https:\/\/doi.org\/10.3389\/fpsyt.2023.1301714 (2023).","journal-title":"Front. Psychiatry"},{"key":"3383_CR77","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","volume":"36","author":"S Ling","year":"2022","unstructured":"Ling, S. et al. Molecular mechanisms of psilocybin and implications for the treatment of depression. CNS Drugs. 36, 17\u201330. https:\/\/doi.org\/10.1007\/s40263-021-00877-y (2022).","journal-title":"CNS Drugs"},{"key":"3383_CR78","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","volume":"26","author":"R Moliner","year":"2023","unstructured":"Moliner, R. et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat. Neurosci. 26, 1032\u20131041. https:\/\/doi.org\/10.1038\/s41593-023-01316-5 (2023).","journal-title":"Nat. Neurosci."},{"key":"3383_CR79","doi-asserted-by":"publisher","first-page":"7472","DOI":"10.1523\/jneurosci.1384-23.2023","volume":"43","author":"LP Cameron","year":"2023","unstructured":"Cameron, L. P. et al. Beyond the 5-HT(2A) receptor: classic and nonclassic targets in psychedelic drug action. J. Neurosci. 43, 7472\u20137482. https:\/\/doi.org\/10.1523\/jneurosci.1384-23.2023 (2023).","journal-title":"J. Neurosci."},{"key":"3383_CR80","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","volume":"28","author":"GR Fries","year":"2023","unstructured":"Fries, G. R., Saldana, V. A., Finnstein, J. & Rein, T. Molecular pathways of major depressive disorder converge on the synapse. Mol. Psychiatry. 28, 284\u2013297. https:\/\/doi.org\/10.1038\/s41380-022-01806-1 (2023).","journal-title":"Mol. Psychiatry"},{"key":"3383_CR81","doi-asserted-by":"publisher","first-page":"1269267","DOI":"10.3389\/fnins.2023.1269267","volume":"17","author":"X Ye","year":"2023","unstructured":"Ye, X. et al. Low-intensity pulsed ultrasound enhances neurite growth in serum-starved human neuroblastoma cells. Front. Neurosci. 17, 1269267. https:\/\/doi.org\/10.3389\/fnins.2023.1269267 (2023).","journal-title":"Front. Neurosci."},{"key":"3383_CR82","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/bcp.12845","volume":"82","author":"ZM Ign\u00e1cio","year":"2016","unstructured":"Ign\u00e1cio, Z. M. et al. New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs. Br. J. Clin. Pharmacol. 82, 1280\u20131290. https:\/\/doi.org\/10.1111\/bcp.12845 (2016).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"3383_CR83","doi-asserted-by":"publisher","first-page":"113709","DOI":"10.1016\/j.bbr.2021.113709","volume":"419","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Deep brain stimulation improved depressive-like behaviors and hippocampal synapse deficits by activating the BDNF\/mTOR signaling pathway. Behav. Brain Res. 419, 113709. https:\/\/doi.org\/10.1016\/j.bbr.2021.113709 (2022).","journal-title":"Behav. Brain Res."},{"key":"3383_CR84","doi-asserted-by":"publisher","first-page":"109325","DOI":"10.1016\/j.neuropharm.2022.109325","volume":"223","author":"T Kato","year":"2023","unstructured":"Kato, T. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants. Neuropharmacology 223, 109325. https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109325 (2023).","journal-title":"Neuropharmacology"},{"key":"3383_CR85","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","volume":"25","author":"JY Hansen","year":"2022","unstructured":"Hansen, J. Y. et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat. Neurosci. 25, 1569\u20131581. https:\/\/doi.org\/10.1038\/s41593-022-01186-3 (2022).","journal-title":"Nat. Neurosci."},{"key":"3383_CR86","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1176\/appi.neuropsych.15030053","volume":"28","author":"GE Tafet","year":"2016","unstructured":"Tafet, G. E. & Nemeroff, C. B. The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions. J. Neuropsychiatry Clin. Neurosci. 28, 77\u201388. https:\/\/doi.org\/10.1176\/appi.neuropsych.15030053 (2016).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"3383_CR87","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fnbeh.2018.00127","volume":"12","author":"LD Godoy","year":"2018","unstructured":"Godoy, L. D., Rossignoli, M. T., Delfino-Pereira, P. & Garcia-Cairasco, N. Lima Umeoka, E. H. A comprehensive overview on stress neurobiology: basic concepts and clinical implications. Front. Behav. Neurosci. 12, 127. https:\/\/doi.org\/10.3389\/fnbeh.2018.00127 (2018). de.","journal-title":"Front. Behav. Neurosci."},{"key":"3383_CR88","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fncir.2017.00086","volume":"11","author":"Y Yang","year":"2017","unstructured":"Yang, Y. & Wang, J. Z. From structure to behavior in basolateral Amygdala-Hippocampus circuits. Front. Neural Circuits. 11, 86. https:\/\/doi.org\/10.3389\/fncir.2017.00086 (2017).","journal-title":"Front. Neural Circuits"},{"key":"3383_CR89","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrn2648","volume":"10","author":"AF Arnsten","year":"2009","unstructured":"Arnsten, A. F. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 10, 410\u2013422. https:\/\/doi.org\/10.1038\/nrn2648 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"3383_CR90","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/npp.2014.24","volume":"39","author":"P Zhong","year":"2014","unstructured":"Zhong, P. et al. Monoacylglycerol lipase Inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling. Neuropsychopharmacology 39, 1763\u20131776. https:\/\/doi.org\/10.1038\/npp.2014.24 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"3383_CR91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.31887\/DCNS.2020.22.3\/rmaldonado","volume":"22","author":"R Maldonado","year":"2020","unstructured":"Maldonado, R., Caba\u00f1ero, D. & Mart\u00edn-Garc\u00eda, E. The endocannabinoid system in modulating fear, anxiety, and stress. Dialogues Clin. Neurosci. 22, 229\u2013239. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/rmaldonado (2020).","journal-title":"Dialogues Clin. Neurosci."},{"key":"3383_CR92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/can.2019.0041","volume":"5","author":"Y Bouter","year":"2020","unstructured":"Bouter, Y. et al. Chronic psychosocial stress causes increased Anxiety-Like behavior and alters endocannabinoid levels in the brain of C57Bl\/6J mice. Cannabis Cannabinoid Res. 5, 51\u201361. https:\/\/doi.org\/10.1089\/can.2019.0041 (2020).","journal-title":"Cannabis Cannabinoid Res."},{"key":"3383_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/02698811221140011","volume":"37","author":"M Marguilho","year":"2023","unstructured":"Marguilho, M., Figueiredo, I. & Castro-Rodrigues, P. A unified model of ketamine\u2019s dissociative and psychedelic properties. J. Psychopharmacol. 37, 14\u201332. https:\/\/doi.org\/10.1177\/02698811221140011 (2023).","journal-title":"J. Psychopharmacol."},{"key":"3383_CR94","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1089\/can.2022.0072","volume":"8","author":"PH Gobira","year":"2023","unstructured":"Gobira, P. H. et al. CB1 receptor Silencing attenuates Ketamine-Induced hyperlocomotion without compromising its Antidepressant-Like effects. Cannabis Cannabinoid Res. 8, 768\u2013778. https:\/\/doi.org\/10.1089\/can.2022.0072 (2023).","journal-title":"Cannabis Cannabinoid Res."},{"key":"3383_CR95","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/bph.15977","volume":"180","author":"A Inserra","year":"2023","unstructured":"Inserra, A. et al. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut Microbiome. Br. J. Pharmacol. 180, 721\u2013739. https:\/\/doi.org\/10.1111\/bph.15977 (2023).","journal-title":"Br. J. Pharmacol."},{"key":"3383_CR96","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.bpsc.2024.02.001","volume":"9","author":"Y Schmid","year":"2024","unstructured":"Schmid, Y. & Bershad, A. K. Altered States and social bonds: effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying Substance-Assisted therapy. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 9, 490\u2013499. https:\/\/doi.org\/10.1016\/j.bpsc.2024.02.001 (2024).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"3383_CR97","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fphar.2017.00455","volume":"8","author":"DJ Puxty","year":"2017","unstructured":"Puxty, D. J. et al. MDMA-Induced dissociative state not mediated by the 5-HT(2A) receptor. Front. Pharmacol. 8, 455. https:\/\/doi.org\/10.3389\/fphar.2017.00455 (2017).","journal-title":"Front. Pharmacol."},{"key":"3383_CR98","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/138945010790980330","volume":"11","author":"P Robledo","year":"2010","unstructured":"Robledo, P. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction. Curr. Drug Targets. 11, 429\u2013439. https:\/\/doi.org\/10.2174\/138945010790980330 (2010).","journal-title":"Curr. Drug Targets"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03383-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03383-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03383-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T14:27:05Z","timestamp":1748269625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03383-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3383"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03383-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5493661\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal procedures strictly complied with the Guidelines of the Canadian Council on Animal Care (CCAC). All treatment and testing procedures were approved by the Animal Care and Use Committees (ACUC) of the Health Sciences Laboratory Animal Services (HSLAS) of the University of Alberta. All experiments were conducted in compliance with the ARRIVE guidelines to enhance transparency, rigor, and reproducibility. This included detailed reporting on study design, experimental conduction, and data analysis to ensure methodological consistency and reliability.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}],"article-number":"18432"}}